Thursday, July 31, 2014
ArtVentive Medical Group, Inc. Announces Excellent Clinical Results and Expanded Enrollment in OCCLUDE I Post-Market Surveillance Study
ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today excellent clinical results in conjunction with expanded enrollment in the ArtVentive Endoluminal Occlusion System, or ArtVentive EOS(TM) device, OCCLUDE I post-market surveillance study.
http://bit.ly/1lgd4cY
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment